4//SEC Filing
Crombez Eric 4
Accession 0000950170-25-063792
CIK 0001515673other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 7:18 PM ET
Size
6.4 KB
Accession
0000950170-25-063792
Insider Transaction Report
Form 4
Crombez Eric
EVP and Chief Medical Officer
Transactions
- Sale
Common Stock
2025-05-05$39.24/sh−520$20,405→ 71,530 total - Sale
Common Stock
2025-04-21$35.11/sh−242$8,497→ 71,680 total
Footnotes (3)
- [F1]Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes 370 shares acquired on April 30, 2025 under the Company's Amended and Restated Employee Stock Purchase Plan
- [F3]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
Documents
Issuer
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
Entity typeother
Related Parties
1- filerCIK 0001653052
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 7:18 PM ET
- Size
- 6.4 KB